🔎 Trials Near Me

Home › Bladder Cancer › Michigan › Warren

Bladder Cancer clinical trials in Warren, MI

4 studies for Bladder Cancer are looking for participants at sites in and around Warren (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RecruitingObservational studyHealthy volunteers welcome
  • Henry Ford Health Warren Hospital, Warren
  • Henry Ford Madison Heights Hospital - Breast, Warren
  • Henry Ford Warren Hospital - GLCMS, Warren
  • and 9 more
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

RecruitingPhase 2
  • Henry Ford Health Warren Hospital, Warren
  • Henry Ford Warren Hospital - GLCMS, Warren
  • Henry Ford Saint John Hospital - Academic, Grosse Pointe Woods · 6 mi away
  • and 1 more
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT03866382

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

RecruitingPhase 2
  • Comprehensive Urology, Royal Oak · 7 mi away
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06567743

The Vanguard Study: Testing a New Way to Screen for Cancer

RecruitingHealthy volunteers welcome
  • Henry Ford Medical Center - Royal Oak, Royal Oak · 7 mi away
  • Henry Ford Medical Center-Cottage, Grosse Pointe Farms · 8 mi away
Ages 45 to 75 · All sexes · Updated Sep 2, 2026 · NCT06995898

About Bladder Cancer

Bladder cancer symptoms range from lower back pain to blood in your urine. Read about important risk factors and find a list of treatments available

More about Bladder Cancer on MedlinePlus

Bladder Cancer trials in other cities

Other studies in Warren

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.